Can ABCF2 protein expression predict the prognosis of uterine cancer?
Author Information
Author(s): Nishimura S, Tsuda H, Miyagi Y, Hirasawa A, Suzuki A, Kataoka F, Nomura H, Chiyoda T, Banno K, Fujii T, Susumu N, Aoki D
Primary Institution: Osaka City General Hospital
Hypothesis
Does ABCF2 protein expression correlate with clinical factors and prognosis in uterine cervical and endometrial cancer?
Conclusion
ABCF2 expression may be a useful prognostic marker in cervical cancer but not in endometrial cancer.
Supporting Evidence
- ABCF2 positivity was found in 55.8% of cervical cancer cases.
- Overall survival was longer in ABCF2-negative than ABCF2-positive cervical cancer cases.
- ABCF2 positivity was an independent prognostic factor in cervical cancer.
Takeaway
This study looked at a protein called ABCF2 to see if it can help predict how well patients with cervical and endometrial cancer will do. It found that ABCF2 might be helpful for cervical cancer but not for endometrial cancer.
Methodology
The study analyzed 385 clinical samples using immunohistochemical staining to detect ABCF2 expression and assessed its relationship with clinical factors and prognosis.
Limitations
The study's findings may not be generalizable due to the specific population and sample size.
Participant Demographics
The median ages of cervical and endometrial cancer patients were 53 (range 22–92) and 55 years (range 32–77), respectively.
Statistical Information
P-Value
P=0.0069
Confidence Interval
95% CI, P=0.00137
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website